Data Standardisation Strategy stakeholder workshop
Table of contents
EMA has launched an initiative to develop a data standards strategy, with a view to addressing the HMA/EMA Big Data Task Force recommendation to engage in international initiatives related to data standardisation.
The strategy will enable the European medicines regulatory network to leverage data more effectively to deliver evidence in support of benefit-risk decision-making on the development, authorisation and use of medicines. The intention is to optimise the processing of such data by different stakeholders through improved submission formats tailored to their needs, while ensuring data security.
EMA plans to consult a wide range of stakeholders to understand their data standardisation needs related to the submission, receipt, use and re-use of scientific data at each stage of the medicinal product lifecycle.
-
List item
Agenda - Data Standardisation Strategy stakeholder workshop (PDF/342.72 KB)
Draft
First published: 05/05/2021
Last updated: 17/05/2021
EMA/346477/2020 -
List item
Presentation - Data initiatives in the veterinary domain (I. Del Seppia, EMA) (PDF/377.38 KB)
First published: 21/05/2021 -
List item
Presentation - Importance of Data Standards in the European Health Data Space (L. Kustra-Mano, DG SANTE) (PDF/728.38 KB)
First published: 21/05/2021 -
List item
Presentation - Overview of the HMA EMA Big Data Taskforce priority 9 and the need for the EMRN Data Standardisation Strategy (J. Kjær, Danish Medicines Agency) (PDF/593.49 KB)
First published: 21/05/2021 -
List item
Presentation - Session 1: EMRN Data Standardisation Strategy development process and status (N. Halsey, EMA) (PDF/878.86 KB)
First published: 21/05/2021 -
List item
Presentation - Session 1: Potential synergies from existing standards and projects CDISC (D. Evans, CDISC) (PDF/1.13 MB)
First published: 21/05/2021 -
List item
Presentation - Session 1: Potential synergies from existing standards and projects EHDEN OHDSI (P. Rijnbeek, EHDEN) (PDF/1.74 MB)
First published: 21/05/2021 -
List item
Presentation - Session 1: Potential synergies from existing standards and projects HL7 (W. Kubick, HL7 International) (PDF/946.99 KB)
First published: 21/05/2021 -
List item
Presentation - Session 1: Potential synergies from existing standards and projects ISO CEN (C. Hay, GS1) (PDF/312.18 KB)
First published: 21/05/2021 -
List item
Presentation - Session 1: Potential synergies from existing standards and projects TEHDAS (E. Bernal Delgado, IACS) (PDF/437.49 KB)
First published: 21/05/2021 -
List item
Presentation - Session 1: Stakeholder consultation (preliminary) main highlights (N. Halsey, EMA) (PDF/1.31 MB)
First published: 21/05/2021 -
List item
Presentation - Session 2: Stakeholder perspective - European Network Data Board (P. Bachman) (PDF/358.94 KB)
First published: 21/05/2021 -
List item
Presentation - Session 2: Stakeholder perspective and use cases - Patients Consumers (M. Vrana, EHN) (PDF/346.56 KB)
First published: 21/05/2021 -
List item
Presentation - Session 2: Stakeholder perspective and use cases - Pharmaceutical industry EFPIA EuropaBio (V. Perkins) (PDF/306.72 KB)
First published: 21/05/2021 -
List item
Presentation - Session 2: Stakeholder perspective and use cases - Pharmaceutical industry EUCOPE (T. Case, M. Ericson) (PDF/599.81 KB)
First published: 21/05/2021 -
List item
Presentation - Session 2: Stakeholder perspective and use cases - Pharmaceutical industry Medicines for Europe (K. Zou) (PDF/317.6 KB)
First published: 21/05/2021 -
List item
Presentation - Session 2: Stakeholder perspective and use cases - Researchers (J-W. Boiten) (PDF/1.09 MB)
First published: 21/05/2021 -
List item
Presentation - Session 2: Stakeholder perspective and use cases healthcare professionals (I. Agache) (PDF/366.78 KB)
First published: 03/06/2021